65 Shares in Stryker Corporation $SYK Purchased by Mid American Wealth Advisory Group Inc.

Mid American Wealth Advisory Group Inc. acquired a new stake in Stryker Corporation (NYSE:SYK) during the second quarter, according to its most recent 13F filing with the SEC. The fund acquired 65 shares of the medical technology company’s stock, valued at approximately $26,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Sachetta LLC boosted its holdings in Stryker by 58.7% in the 2nd quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock worth $29,000 after buying an additional 27 shares during the period. Goodman Advisory Group LLC purchased a new stake in shares of Stryker during the first quarter worth $32,000. Ridgewood Investments LLC boosted its holdings in shares of Stryker by 48.4% in the second quarter. Ridgewood Investments LLC now owns 92 shares of the medical technology company’s stock worth $36,000 after acquiring an additional 30 shares during the period. Ransom Advisory Ltd purchased a new position in shares of Stryker in the first quarter valued at $37,000. Finally, Smallwood Wealth Investment Management LLC bought a new stake in shares of Stryker during the 1st quarter valued at $40,000. Institutional investors own 77.09% of the company’s stock.

Analyst Upgrades and Downgrades

SYK has been the subject of a number of recent analyst reports. BTIG Research lifted their target price on Stryker from $407.00 to $408.00 and gave the company a “buy” rating in a report on Monday, October 13th. Rothschild & Co Redburn started coverage on shares of Stryker in a research note on Thursday, September 18th. They set a “neutral” rating and a $420.00 price objective for the company. Evercore ISI lowered their target price on shares of Stryker from $418.00 to $410.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 7th. Rothschild Redb raised shares of Stryker to a “hold” rating in a report on Thursday, September 18th. Finally, Wall Street Zen raised shares of Stryker from a “hold” rating to a “buy” rating in a report on Saturday. Fifteen equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $431.76.

Stryker Stock Performance

NYSE SYK opened at $381.27 on Tuesday. Stryker Corporation has a 52-week low of $329.16 and a 52-week high of $406.19. The company has a fifty day moving average of $379.49 and a 200-day moving average of $379.09. The company has a market capitalization of $145.76 billion, a P/E ratio of 50.50, a P/E/G ratio of 2.70 and a beta of 0.94. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.06 and a current ratio of 1.78.

Stryker (NYSE:SYK) last released its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.13 earnings per share for the quarter, beating analysts’ consensus estimates of $3.07 by $0.06. Stryker had a return on equity of 23.94% and a net margin of 12.25%.The business had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $5.92 billion. During the same quarter last year, the business posted $2.81 earnings per share. The company’s revenue for the quarter was up 11.1% on a year-over-year basis. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. As a group, equities research analysts predict that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be paid a $0.84 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $3.36 annualized dividend and a yield of 0.9%. Stryker’s dividend payout ratio is currently 44.50%.

Insider Buying and Selling

In related news, insider Viju Menon sold 500 shares of Stryker stock in a transaction on Monday, August 25th. The shares were sold at an average price of $390.61, for a total value of $195,305.00. Following the transaction, the insider owned 12,511 shares in the company, valued at $4,886,921.71. This trade represents a 3.84% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Ronda E. Stryker sold 200,000 shares of the business’s stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the completion of the sale, the director directly owned 3,222,108 shares of the company’s stock, valued at $1,212,962,556.60. This represents a 5.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. 5.20% of the stock is owned by company insiders.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.